BACKGROUND: Many patients referred for an elevated serum ferritin level <1000 µg⁄L are advised that they likely have iron overload and hemochromatosis. AIMS: To determine the prevalence of HFE mutations in the hemochromatosis gene for 11 serum ferritin concentration intervals from 200 µg⁄L to 1000 µg⁄L in Caucasian participants in a primary care, population-based study. METHODS: The Hemochromatosis and Iron Overload Screening study screened 99,711 participants for serum ferritin levels, transferrin saturation and genetic testing for the C282Y and H63D mutations of the HFE gene. This analysis was confined to 17,160 male and 27,465 female Caucasian participants because the HFE C282Y mutation is rare in other races. Post-test likelihood was calculated for prediction of C282Y homozygosity from a ferritin interval. A subgroup analysis was performed in participants with both an elevated serum ferritin level and transferrin saturation. RESULTS: There were 3359 male and 2416 female participants with an elevated serum ferritin level (200 µg⁄L to 1000 µg⁄L for women, 300 µg⁄L to 1000 µg⁄L for men). There were 69 male (2.1%) and 87 female (3.6%) C282Y homozygotes, and the probability of being a homozygote increased as the ferritin level increased. Post-test likelihood values were 0.3% to 16% in men and 0.3% to 30.4% in women. CONCLUSIONS: Iron loading HFE mutations are unlikely to be the most common cause of an elevated serum ferritin level in patients with mild hyperferritinemia. Patients should be advised that there are many causes of an elevated serum ferritin level including iron overload.
BACKGROUND: Many patients referred for an elevated serum ferritin level <1000 µg⁄L are advised that they likely have iron overload and hemochromatosis. AIMS: To determine the prevalence of HFE mutations in the hemochromatosis gene for 11 serum ferritin concentration intervals from 200 µg⁄L to 1000 µg⁄L in Caucasian participants in a primary care, population-based study. METHODS: The Hemochromatosis and Iron Overload Screening study screened 99,711 participants for serum ferritin levels, transferrin saturation and genetic testing for the C282Y and H63D mutations of the HFE gene. This analysis was confined to 17,160 male and 27,465 female Caucasian participants because the HFEC282Y mutation is rare in other races. Post-test likelihood was calculated for prediction of C282Y homozygosity from a ferritin interval. A subgroup analysis was performed in participants with both an elevated serum ferritin level and transferrin saturation. RESULTS: There were 3359 male and 2416 female participants with an elevated serum ferritin level (200 µg⁄L to 1000 µg⁄L for women, 300 µg⁄L to 1000 µg⁄L for men). There were 69 male (2.1%) and 87 female (3.6%) C282Y homozygotes, and the probability of being a homozygote increased as the ferritin level increased. Post-test likelihood values were 0.3% to 16% in men and 0.3% to 30.4% in women. CONCLUSIONS:Iron loading HFE mutations are unlikely to be the most common cause of an elevated serum ferritin level in patients with mild hyperferritinemia. Patients should be advised that there are many causes of an elevated serum ferritin level including iron overload.
Authors: James C Barton; J Clayborn Barton; Ronald T Acton; Jeffrey So; Susanne Chan; Paul C Adams Journal: Clin Gastroenterol Hepatol Date: 2012-01-17 Impact factor: 11.382
Authors: Paul C Adams; Leah Passmore; Subrata Chakrabarti; David M Reboussin; Ronald T Acton; James C Barton; Gordon D McLaren; John H Eckfeldt; Fitzroy W Dawkins; Victor R Gordeuk; Emily L Harris; Catherine Leiendecker-Foster; Elaine Gossman; Phyliss Sholinsky Journal: Clin Gastroenterol Hepatol Date: 2006-07 Impact factor: 11.382
Authors: Ronald T Acton; James C Barton; Leah V Passmore; Paul C Adams; Mark R Speechley; Fitzroy W Dawkins; Phyliss Sholinsky; David M Reboussin; Gordon D McLaren; Emily L Harris; Thomas C Bent; Thomas M Vogt; Oswaldo Castro Journal: Diabetes Care Date: 2006-09 Impact factor: 19.112
Authors: Katrina J Allen; Nadine A Bertalli; Nicholas J Osborne; Clare C Constantine; Martin B Delatycki; Amy E Nisselle; Amanda J Nicoll; Dorota M Gertig; Christine E McLaren; Graham G Giles; John L Hopper; Gregory J Anderson; John K Olynyk; Lawrie W Powell; Lyle C Gurrin Journal: Hepatology Date: 2010-09 Impact factor: 17.425
Authors: Christine E McLaren; James C Barton; Paul C Adams; Emily L Harris; Ronald T Acton; Nancy Press; David M Reboussin; Gordon D McLaren; Phyliss Sholinsky; Ann P Walker; Victor R Gordeuk; Catherine Leiendecker-Foster; Fitzroy W Dawkins; John H Eckfeldt; Beverly G Mellen; Mark Speechley; Elizabeth Thomson Journal: Am J Med Sci Date: 2003-02 Impact factor: 2.378
Authors: Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky Journal: N Engl J Med Date: 2005-04-28 Impact factor: 91.245
Authors: James C Barton; Susie A Lafreniere; Catherine Leiendecker-Foster; Honggui Li; Ronald T Acton; Richard D Press; John H Eckfeldt Journal: Am J Hematol Date: 2009-11 Impact factor: 10.047
Authors: Clara Podmore; Karina Meidtner; Matthias B Schulze; Robert A Scott; Anna Ramond; Adam S Butterworth; Emanuele Di Angelantonio; John Danesh; Larraitz Arriola; Aurelio Barricarte; Heiner Boeing; Françoise Clavel-Chapelon; Amanda J Cross; Christina C Dahm; Guy Fagherazzi; Paul W Franks; Diana Gavrila; Sara Grioni; Marc J Gunter; Gaelle Gusto; Paula Jakszyn; Verena Katzke; Timothy J Key; Tilman Kühn; Amalia Mattiello; Peter M Nilsson; Anja Olsen; Kim Overvad; Domenico Palli; J Ramón Quirós; Olov Rolandsson; Carlotta Sacerdote; Emilio Sánchez-Cantalejo; Nadia Slimani; Ivonne Sluijs; Annemieke M W Spijkerman; Anne Tjonneland; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Edith J M Feskens; Nita G Forouhi; Stephen J Sharp; Elio Riboli; Claudia Langenberg; Nicholas J Wareham Journal: Diabetes Care Date: 2016-02-09 Impact factor: 19.112
Authors: Marzanna Obrzut; Vitaliy Atamaniuk; Kevin J Glaser; Jun Chen; Richard L Ehman; Bogdan Obrzut; Marian Cholewa; Krzysztof Gutkowski Journal: Sci Rep Date: 2020-10-21 Impact factor: 4.379